{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,10]],"date-time":"2026-01-10T01:16:03Z","timestamp":1768007763635,"version":"3.49.0"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100012155","name":"National Institute for Medical Research Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012155","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1016\/j.ejphar.2019.03.046","type":"journal-article","created":{"date-parts":[[2019,3,28]],"date-time":"2019-03-28T05:49:00Z","timestamp":1553752140000},"page":"256-263","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":51,"special_numbering":"C","title":["TLR4 blockade using TAK-242 suppresses ovarian and breast cancer cells invasion through the inhibition of extracellular matrix degradation and epithelial-mesenchymal transition"],"prefix":"10.1016","volume":"853","author":[{"given":"Zahra","family":"Zandi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bahareh","family":"Kashani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ensieh M.","family":"Poursani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Davood","family":"Bashash","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Majid","family":"Kabuli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Majid","family":"Momeny","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seyedeh H.","family":"Mousavi-pak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fatemeh","family":"Sheikhsaran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kamran","family":"Alimoghaddam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seyed A.","family":"Mousavi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seyed H.","family":"Ghaffari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.ejphar.2019.03.046_bib1","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1038\/nrm977","article-title":"uPAR: a versatile signalling orchestrator","volume":"3","author":"Blasi","year":"2002","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"5","key":"10.1016\/j.ejphar.2019.03.046_bib2","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1158\/1940-6207.CAPR-17-0349","article-title":"Pharmacological TLR4 antagonism using topical resatorvid blocks solar UV-induced skin tumorigenesis in SKH-1 mice","volume":"11","author":"Blohm-Mangone","year":"2018","journal-title":"Cancer Prev. Res."},{"issue":"4","key":"10.1016\/j.ejphar.2019.03.046_bib3","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1177\/0022034510381264","article-title":"TLR-signaling networks: an integration of adaptor molecules, kinases, and cross-talk","volume":"90","author":"Brown","year":"2011","journal-title":"J. Dent. Res."},{"issue":"5","key":"10.1016\/j.ejphar.2019.03.046_bib4","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/j.coi.2008.04.012","article-title":"HMGB1: a two-headed signal regulating tumor progression and immunity","volume":"20","author":"Campana","year":"2008","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.ejphar.2019.03.046_bib5","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.cellsig.2017.03.017","article-title":"Therapeutic implication of \u2018Iturin A\u2019for targeting MD-2\/TLR4 complex to overcome angiogenesis and invasion","volume":"35","author":"Dey","year":"2017","journal-title":"Cell. Signal."},{"issue":"2","key":"10.1016\/j.ejphar.2019.03.046_bib6","doi-asserted-by":"crossref","first-page":"e11","DOI":"10.1016\/j.jid.2016.11.020","article-title":"Research techniques made simple: analysis of collective cell migration using the wound healing assay","volume":"137","author":"Grada","year":"2017","journal-title":"J. Investig. Dermatol."},{"issue":"33","key":"10.1016\/j.ejphar.2019.03.046_bib7","doi-asserted-by":"crossref","first-page":"13667","DOI":"10.1073\/pnas.0906423106","article-title":"Targeted inhibition of Snail family zinc finger transcription factors by oligonucleotide-Co (III) Schiff base conjugate","volume":"106","author":"Harney","year":"2009","journal-title":"Proc. Natl. Acad. Sci. Unit. States Am."},{"issue":"4","key":"10.1016\/j.ejphar.2019.03.046_bib8","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1124\/mol.105.019695","article-title":"A novel cyclohexene derivative, ethyl (6R)-6-[N-(2-Chloro-4-fluorophenyl) sulfamoyl] cyclohex-1-ene-1-carboxylate (TAK-242), selectively inhibits toll-like receptor 4-mediated cytokine production through suppression of intracellular signaling","volume":"69","author":"Li","year":"2006","journal-title":"Mol. Pharmacol."},{"issue":"Suppl. 1","key":"10.1016\/j.ejphar.2019.03.046_bib9","doi-asserted-by":"crossref","first-page":"177","DOI":"10.3109\/14756366.2016.1161620","article-title":"Matrix metalloproteinases (MMPs), the main extracellular matrix (ECM) enzymes in collagen degradation, as a target for anticancer drugs","volume":"31","author":"Jab\u0142o\u0144ska-Trypu\u0107","year":"2016","journal-title":"J. Enzym. Inhib. Med. Chem."},{"issue":"6","key":"10.1016\/j.ejphar.2019.03.046_bib10","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1111\/php.12659","article-title":"Resatorvid\u2010based pharmacological antagonism of cutaneous TLR4 blocks UV\u2010induced NF\u2010\u03baB and AP\u20101 signaling in keratinocytes and mouse skin","volume":"92","author":"Janda","year":"2016","journal-title":"Photochem. Photobiol."},{"issue":"6","key":"10.1016\/j.ejphar.2019.03.046_bib11","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1172\/JCI39104","article-title":"The basics of epithelial-mesenchymal transition","volume":"119","author":"Kalluri","year":"2009","journal-title":"J. Clin. Investig."},{"issue":"1","key":"10.1016\/j.ejphar.2019.03.046_bib12","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.ejphar.2008.01.026","article-title":"TAK-242 selectively suppresses Toll-like receptor 4-signaling mediated by the intracellular domain","volume":"584","author":"Kawamoto","year":"2008","journal-title":"Eur. J. Pharmacol."},{"issue":"1","key":"10.1016\/j.ejphar.2019.03.046_bib13","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.ygyno.2004.12.043","article-title":"Snail and Slug are major determinants of ovarian cancer invasiveness at the transcription level","volume":"97","author":"Kurrey","year":"2005","journal-title":"Gynecol. Oncol."},{"issue":"3","key":"10.1016\/j.ejphar.2019.03.046_bib14","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1038\/nrm3758","article-title":"Molecular mechanisms of epithelial\u2013mesenchymal transition","volume":"15","author":"Lamouille","year":"2014","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"7","key":"10.1016\/j.ejphar.2019.03.046_bib15","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1002\/ar.23590","article-title":"TLR4 promotes breast cancer metastasis via Akt\/GSK3\u03b2\/\u03b2\u2010catenin pathway upon LPS stimulation","volume":"300","author":"Li","year":"2017","journal-title":"Anat. Rec."},{"issue":"12","key":"10.1016\/j.ejphar.2019.03.046_bib16","doi-asserted-by":"crossref","first-page":"a005058","DOI":"10.1101\/cshperspect.a005058","article-title":"Extracellular matrix degradation and remodeling in development and disease","volume":"3","author":"Lu","year":"2011","journal-title":"Cold Spring Harbor perspectives in biology"},{"key":"10.1016\/j.ejphar.2019.03.046_bib17","first-page":"1573","article-title":"Should a Toll-like receptor 4 (TLR-4) agonist or antagonist be designed to treat cancer? TLR-4: its expression and effects in the ten most common cancers","volume":"6","author":"Mai","year":"2013","journal-title":"OncoTargets Ther."},{"key":"10.1016\/j.ejphar.2019.03.046_bib18","doi-asserted-by":"crossref","first-page":"21903","DOI":"10.1038\/srep21903","article-title":"Simultaneous knockdown of uPA and MMP9 can reduce breast cancer progression by increasing cell-cell adhesion and modulating EMT genes","volume":"6","author":"Moirangthem","year":"2016","journal-title":"Sci. Rep."},{"issue":"21","key":"10.1016\/j.ejphar.2019.03.046_bib19","doi-asserted-by":"crossref","first-page":"3233","DOI":"10.1091\/mbc.E16-01-0058","article-title":"Roles for E-cadherin cell surface regulation in cancer","volume":"27","author":"Petrova","year":"2016","journal-title":"Mol. Biol. Cell"},{"issue":"59","key":"10.1016\/j.ejphar.2019.03.046_bib20","doi-asserted-by":"crossref","first-page":"99482","DOI":"10.18632\/oncotarget.20107","article-title":"Inhibition of ZEB1 leads to inversion of metastatic characteristics and restoration of paclitaxel sensitivity of chronic chemoresistant ovarian carcinoma cells","volume":"8","author":"Sakata","year":"2017","journal-title":"Oncotarget"},{"issue":"1","key":"10.1016\/j.ejphar.2019.03.046_bib21","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/s12307-009-0022-y","article-title":"Cancer cells expressing toll-like receptors and the tumor microenvironment","volume":"2","author":"Sato","year":"2009","journal-title":"Canc. Microenviron."},{"issue":"32","key":"10.1016\/j.ejphar.2019.03.046_bib22","doi-asserted-by":"crossref","first-page":"3745","DOI":"10.3748\/wjg.v17.i32.3745","article-title":"Overexpression of TLR3, TLR4, TLR7 and TLR9 in esophageal squamous cell carcinoma","volume":"17","author":"Sheyhidin","year":"2011","journal-title":"World J. Gastroenterol.: WJG"},{"key":"10.1016\/j.ejphar.2019.03.046_bib23","series-title":"Stress Response Pathways in Cancer","first-page":"375","article-title":"Inflammatory dysregulation and cancer: from molecular mechanisms to therapeutic opportunities","author":"Steele","year":"2015"},{"issue":"3","key":"10.1016\/j.ejphar.2019.03.046_bib24","doi-asserted-by":"crossref","first-page":"2489","DOI":"10.1002\/jcp.26125","article-title":"TLR4 and NF\u03baB signaling is critical for taxol resistance in ovarian carcinoma cells","volume":"233","author":"Sun","year":"2018","journal-title":"J. Cell. Physiol."},{"issue":"49","key":"10.1016\/j.ejphar.2019.03.046_bib25","doi-asserted-by":"crossref","first-page":"4353","DOI":"10.1038\/onc.2009.289","article-title":"TLR4 signaling induced by lipopolysaccharide or paclitaxel regulates tumor survival and chemoresistance in ovarian cancer","volume":"28","author":"Szajnik","year":"2009","journal-title":"Oncogene"},{"key":"10.1016\/j.ejphar.2019.03.046_bib26","series-title":"Metastasis Research Protocols","first-page":"121","article-title":"Assessment of gelatinases (MMP-2 and MMP-9) by gelatin zymography","author":"Toth","year":"2012"},{"issue":"10","key":"10.1016\/j.ejphar.2019.03.046_bib27","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0109980","article-title":"Toll-like receptor 4 prompts human breast cancer cells invasiveness via lipopolysaccharide stimulation and is overexpressed in patients with lymph node metastasis","volume":"9","author":"Yang","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.ejphar.2019.03.046_bib28","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.lfs.2016.05.012","article-title":"TLR4 siRNA inhibits proliferation and invasion in colorectal cancer cells by downregulating ACAT1 expression","volume":"155","author":"Ye","year":"2016","journal-title":"Life Sci."},{"issue":"1\u20132","key":"10.1016\/j.ejphar.2019.03.046_bib29","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s10555-008-9169-0","article-title":"EMT, the cytoskeleton, and cancer cell invasion","volume":"28","author":"Yilmaz","year":"2009","journal-title":"Cancer Metastasis Rev."},{"issue":"5","key":"10.1016\/j.ejphar.2019.03.046_bib30","doi-asserted-by":"crossref","first-page":"3339","DOI":"10.4049\/jimmunol.175.5.3339","article-title":"Specific inhibition of MyD88-independent signaling pathways of TLR3 and TLR4 by resveratrol: molecular targets are TBK1 and RIP1 in TRIF complex","volume":"175","author":"Youn","year":"2005","journal-title":"J. Immunol."},{"issue":"1","key":"10.1016\/j.ejphar.2019.03.046_bib31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4149\/neo_2015_002","article-title":"The contribution of TGF-\u03b2 in epithelial-mesenchymal transition (EMT): down-regulation of E-cadherin via snail","volume":"62","author":"Yu","year":"2015","journal-title":"Neoplasma"}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299919302079?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299919302079?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T22:28:14Z","timestamp":1757975294000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299919302079"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6]]},"references-count":31,"alternative-id":["S0014299919302079"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2019.03.046","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2019,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"TLR4 blockade using TAK-242 suppresses ovarian and breast cancer cells invasion through the inhibition of extracellular matrix degradation and epithelial-mesenchymal transition","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2019.03.046","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}